ALGS Latest News, Press Relases and Analysis

All

Press Releases

24 days ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 days ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Aligos Therapeutics

Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025

a month ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

a month ago - By: Benzinga - Mentions: STVN PODD AMRK SOLV ...

Earnings Scheduled For November 6, 2025

4 months ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

a month ago - By: Aligos Therapeutics

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

a month ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at Upcoming Investor Conferences

a month ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at Upcoming Investor Conferences

a month ago - By: Aligos Therapeutics

Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025

a month ago - By: Aligos Therapeutics

Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025

2 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025

3 months ago - By: Zacks Investment Research

Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Aligos Therapeutics

Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Zacks Investment Research - Mentions: SNY ADPT AKRO